Transaction #26710 · Form 4 · 0001213900-26-000712
CorMedix Inc. · Exercise / conversion · Common Stock
CorMedix Inc. · Transacted December 30, 2025 · Filed January 2, 2026
What does this filing report?
An SEC Form 4 filing for CorMedix Inc. records an exercise / conversion involving Common Stock on December 30, 2025. The reported quantity was 20,000. The filing date is January 2, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- CorMedix Inc.
- Company CIK
- 0001410098
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 20,000
- Reported price
- 4.03
- Reference value
- 80,600
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 60,250
- Ownership description
- Not reported
- SEC acceptance time
- Jan 2, 2026, 9:30 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- DUNTON ALAN W ↗
Director
CIK 0001304773
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- These options were granted on 2/22/2022. These options are fully vested.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.